(Q44321529)

1 December 2017

title

Molecular species compositions of lung and pancreas phospholipids in the cftr(tm1HGU/tm1HGU) cystic fibrosis mouse (English)

1 reference

1 December 2017

0 references

0 references

5

1 reference

1 December 2017

Heike Dombrowsky

1

1 reference

1 December 2017

Graeme T Clark

series ordinal

2

1 reference

1 December 2017

Gunnar A Rau

series ordinal

3

1 reference

1 December 2017

Wolfgang Bernhard

series ordinal

4

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

1 December 2017

1 reference

1 December 2017

volume

53

1 reference

1 December 2017

issue

3

1 reference

1 December 2017

page(s)

447-454

1 reference

Fatty acid abnormalities in cystic fibrosis

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

Serum fatty acid profiles in cystic fibrosis patients and their parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

The chloride channel blocker anthracene 9-carboxylate inhibits fatty acid incorporation into phospholipid in cultured human airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

Cystic fibrosis in the mouse by targeted insertional mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

Long-term survival of the exon 10 insertional cystic fibrosis mutant mouse is a consequence of low level residual wild-type Cftr gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

Highly saturated endonuclear phosphatidylcholine is synthesized in situ and colocated with CDP-choline pathway enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

Lung surfactant in a cystic fibrosis animal model: increased alveolar phospholipid pool size without altered composition and surface tension function in cftrm1HGU/m1HGU mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

Membrane docosahexaenoate is supplied to the developing brain and retina by the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

Abnormal fatty-acid composition of plasma-lipids in cystic fibrosis. A primary or a secondary defect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

Essential fatty acids in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

Altered phospholipid composition and changed fatty acid pattern of the various phospholipid fractions of red cell membranes of cystic fibrosis children with pancreatic insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

Fatty acid composition of erythrocyte phospholipids from patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

Abnormal fatty acid pattern of the plasma cholesterol ester fraction in cystic fibrosis patients with and without pancreatic insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

Abnormal fatty acid turnover in the phospholipids of the red blood cell membranes of cystic fibrosis patients (in vitro study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

Cystic fibrosis and phosphatidylcholine biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

Metabolism of surfactant phosphatidylcholine molecular species in cftr(tm1HGU/tm1HGU) mice compared to MF-1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

Structural determination of picomole amounts of phospholipids via electrospray ionization tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

Direct in vivo characterization of delta 5 desaturase activity in humans by deuterium labeling: effect of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

Omega-3 fatty acids suppress the enhanced production of 5-lipoxygenase products from polymorph neutrophil granulocytes in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000049937.30305.8A

10.1203/01.PDR.0000049937.30305.8A

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

1 December 2017

1050845093

0 references

1 reference